Titre : Pharmacoépidémiologie

Pharmacoépidémiologie : Questions médicales fréquentes

Termes MeSH sélectionnés :

Climate Models
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Pharmacoépidémiologie : Questions médicales les plus fréquentes", "headline": "Pharmacoépidémiologie : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Pharmacoépidémiologie : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-05", "dateModified": "2025-03-31", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Pharmacoépidémiologie" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Pharmacologie", "url": "https://questionsmedicales.fr/mesh/D010600", "about": { "@type": "MedicalCondition", "name": "Pharmacologie", "code": { "@type": "MedicalCode", "code": "D010600", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "H02.628" } } }, "about": { "@type": "MedicalCondition", "name": "Pharmacoépidémiologie", "alternateName": "Pharmacoepidemiology", "code": { "@type": "MedicalCode", "code": "D017891", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Agnès Sommet", "url": "https://questionsmedicales.fr/author/Agn%C3%A8s%20Sommet", "affiliation": { "@type": "Organization", "name": "Laboratoire de pharmacologie médicale et clinique, faculté de médecine de Toulouse, 31000 Toulouse, France; Service de pharmacologie médicale et clinique, centre Midi-Pyrénées de pharmacovigilance, pharmacoépidémiologie et d'informations sur le médicament, pharmacopôle, centre hospitalier universitaire de Toulouse, 31000 Toulouse, France." } }, { "@type": "Person", "name": "Jean-Louis Montastruc", "url": "https://questionsmedicales.fr/author/Jean-Louis%20Montastruc", "affiliation": { "@type": "Organization", "name": "Laboratoire de pharmacologie médicale et clinique, faculté de médecine de Toulouse, 31000 Toulouse, France; Service de pharmacologie médicale et clinique, centre Midi-Pyrénées de pharmacovigilance, pharmacoépidémiologie et d'informations sur le médicament, pharmacopôle, centre hospitalier universitaire de Toulouse, 31000 Toulouse, France." } }, { "@type": "Person", "name": "François Montastruc", "url": "https://questionsmedicales.fr/author/Fran%C3%A7ois%20Montastruc", "affiliation": { "@type": "Organization", "name": "Department of Medical and Clinical Pharmacology, Centre of PharmacoVigilance and Pharmacoepidemiology, Toulouse University Hospital, Faculty of Medicine, Toulouse, France." } }, { "@type": "Person", "name": "Maryse Lapeyre-Mestre", "url": "https://questionsmedicales.fr/author/Maryse%20Lapeyre-Mestre", "affiliation": { "@type": "Organization", "name": "Department of Medical and Clinical Pharmacology, Centre of PharmacoVigilance and Pharmacoepidemiology, Toulouse University Hospital, Faculty of Medicine, Toulouse, France." } }, { "@type": "Person", "name": "Anton Pottegård", "url": "https://questionsmedicales.fr/author/Anton%20Potteg%C3%A5rd", "affiliation": { "@type": "Organization", "name": "Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Modeling Sorption of Hydrocarbons in Polyethylene with the SAFT-γ Mie Approach Combined with a Statistical-Mechanical Model to Describe Semicrystalline Polymers.", "datePublished": "2023-12-04", "url": "https://questionsmedicales.fr/article/38161323", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1021/acs.macromol.3c01336" } }, { "@type": "ScholarlyArticle", "name": "A quantitative assessment of the consistency of projections from five mathematical models of the HIV epidemic in South Africa: a model comparison study.", "datePublished": "2023-10-27", "url": "https://questionsmedicales.fr/article/37891514", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12889-023-16995-9" } }, { "@type": "ScholarlyArticle", "name": "Improving microalgae growth modeling of outdoor cultivation with light history data using machine learning models: A comparative study.", "datePublished": "2023-10-24", "url": "https://questionsmedicales.fr/article/37884098", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.biortech.2023.129882" } }, { "@type": "ScholarlyArticle", "name": "Comparing bone shape models from deep learning processing of magnetic resonance imaging to computed tomography-based models.", "datePublished": "2023-05-26", "url": "https://questionsmedicales.fr/article/37719825", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jseint.2023.05.008" } }, { "@type": "ScholarlyArticle", "name": "Use of noise prediction models for road noise mapping in locations that do not have a standardized model: a short systematic review.", "datePublished": "2023-05-26", "url": "https://questionsmedicales.fr/article/37233823", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10661-023-11268-9" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Professions de santé", "item": "https://questionsmedicales.fr/mesh/D006281" }, { "@type": "ListItem", "position": 3, "name": "Pharmacologie", "item": "https://questionsmedicales.fr/mesh/D010600" }, { "@type": "ListItem", "position": 4, "name": "Pharmacoépidémiologie", "item": "https://questionsmedicales.fr/mesh/D017891" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Pharmacoépidémiologie - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Pharmacoépidémiologie", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-18", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Pharmacoépidémiologie", "description": "Comment évaluer l'impact d'un médicament sur la population ?\nQuels outils sont utilisés pour le diagnostic pharmacoépidémiologique ?\nQuelles sont les méthodes d'analyse en pharmacoépidémiologie ?\nComment identifier les effets indésirables des médicaments ?\nQuel rôle joue la surveillance dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D017891?mesh_terms=Climate+Models&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Pharmacoépidémiologie", "description": "Quels symptômes peuvent indiquer une réaction médicamenteuse ?\nComment les symptômes varient-ils selon les populations ?\nQuels sont les symptômes d'une surdose médicamenteuse ?\nComment les symptômes sont-ils rapportés en études ?\nQuels outils mesurent les symptômes liés aux médicaments ?", "url": "https://questionsmedicales.fr/mesh/D017891?mesh_terms=Climate+Models&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Pharmacoépidémiologie", "description": "Comment prévenir les effets indésirables des médicaments ?\nQuels programmes aident à prévenir les erreurs médicamenteuses ?\nComment la vaccination est-elle intégrée en pharmacoépidémiologie ?\nQuel rôle joue l'information dans la prévention ?\nComment les campagnes de sensibilisation influencent-elles la prévention ?", "url": "https://questionsmedicales.fr/mesh/D017891?mesh_terms=Climate+Models&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Pharmacoépidémiologie", "description": "Comment évaluer l'efficacité d'un traitement médicamenteux ?\nQuels traitements sont souvent étudiés en pharmacoépidémiologie ?\nComment les interactions médicamenteuses sont-elles gérées ?\nQuel est l'impact des traitements sur la qualité de vie ?\nComment les traitements sont-ils adaptés aux populations spécifiques ?", "url": "https://questionsmedicales.fr/mesh/D017891?mesh_terms=Climate+Models&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Pharmacoépidémiologie", "description": "Quelles complications peuvent survenir avec certains médicaments ?\nComment les complications sont-elles surveillées ?\nQuel est l'impact des complications sur la santé publique ?\nComment prévenir les complications liées aux médicaments ?\nQuels facteurs augmentent le risque de complications ?", "url": "https://questionsmedicales.fr/mesh/D017891?mesh_terms=Climate+Models&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Pharmacoépidémiologie", "description": "Quels sont les principaux facteurs de risque en pharmacoépidémiologie ?\nComment les comorbidités influencent-elles les traitements ?\nQuel rôle joue la génétique dans les facteurs de risque ?\nComment les habitudes de vie affectent-elles la santé médicamenteuse ?\nQuels outils évaluent les facteurs de risque ?", "url": "https://questionsmedicales.fr/mesh/D017891?mesh_terms=Climate+Models&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment évaluer l'impact d'un médicament sur la population ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'impact est évalué par des études d'observation et des analyses statistiques." } }, { "@type": "Question", "name": "Quels outils sont utilisés pour le diagnostic pharmacoépidémiologique ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des bases de données de santé, des registres et des enquêtes sont utilisés." } }, { "@type": "Question", "name": "Quelles sont les méthodes d'analyse en pharmacoépidémiologie ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les méthodes incluent l'analyse de régression, les études cas-témoins et les méta-analyses." } }, { "@type": "Question", "name": "Comment identifier les effets indésirables des médicaments ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les effets indésirables sont identifiés par des études de pharmacovigilance et des rapports." } }, { "@type": "Question", "name": "Quel rôle joue la surveillance dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "La surveillance permet de détecter rapidement les problèmes de sécurité des médicaments." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer une réaction médicamenteuse ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme des éruptions cutanées, des nausées ou des vertiges peuvent survenir." } }, { "@type": "Question", "name": "Comment les symptômes varient-ils selon les populations ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent varier en fonction de l'âge, du sexe et des comorbidités." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une surdose médicamenteuse ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent confusion, somnolence, nausées et troubles respiratoires." } }, { "@type": "Question", "name": "Comment les symptômes sont-ils rapportés en études ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes sont rapportés par les patients, les médecins et les bases de données." } }, { "@type": "Question", "name": "Quels outils mesurent les symptômes liés aux médicaments ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des questionnaires standardisés et des échelles d'évaluation sont utilisés." } }, { "@type": "Question", "name": "Comment prévenir les effets indésirables des médicaments ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention inclut l'éducation des patients et la surveillance des prescriptions." } }, { "@type": "Question", "name": "Quels programmes aident à prévenir les erreurs médicamenteuses ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Des programmes de formation et des systèmes de double vérification sont mis en place." } }, { "@type": "Question", "name": "Comment la vaccination est-elle intégrée en pharmacoépidémiologie ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "La vaccination est étudiée pour évaluer son efficacité et ses effets secondaires dans la population." } }, { "@type": "Question", "name": "Quel rôle joue l'information dans la prévention ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "L'information aide les patients à comprendre les risques et à suivre les traitements correctement." } }, { "@type": "Question", "name": "Comment les campagnes de sensibilisation influencent-elles la prévention ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Les campagnes augmentent la sensibilisation aux risques et encouragent des comportements sûrs." } }, { "@type": "Question", "name": "Comment évaluer l'efficacité d'un traitement médicamenteux ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "L'efficacité est évaluée par des essais cliniques et des études d'observation." } }, { "@type": "Question", "name": "Quels traitements sont souvent étudiés en pharmacoépidémiologie ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements pour les maladies chroniques, les infections et les cancers sont courants." } }, { "@type": "Question", "name": "Comment les interactions médicamenteuses sont-elles gérées ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les interactions sont gérées par des recommandations cliniques et des alertes de sécurité." } }, { "@type": "Question", "name": "Quel est l'impact des traitements sur la qualité de vie ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements peuvent améliorer la qualité de vie, mais des effets secondaires peuvent survenir." } }, { "@type": "Question", "name": "Comment les traitements sont-ils adaptés aux populations spécifiques ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements sont adaptés en fonction de l'âge, du sexe et des caractéristiques génétiques." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec certains médicaments ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme des réactions allergiques, des troubles hépatiques ou rénaux peuvent survenir." } }, { "@type": "Question", "name": "Comment les complications sont-elles surveillées ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Les complications sont surveillées par des systèmes de pharmacovigilance et des rapports cliniques." } }, { "@type": "Question", "name": "Quel est l'impact des complications sur la santé publique ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent augmenter les coûts de santé et affecter la qualité de vie des patients." } }, { "@type": "Question", "name": "Comment prévenir les complications liées aux médicaments ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "La prévention passe par une prescription appropriée et un suivi régulier des patients." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge, les comorbidités et les interactions médicamenteuses." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque en pharmacoépidémiologie ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge, le sexe, les antécédents médicaux et les habitudes de vie." } }, { "@type": "Question", "name": "Comment les comorbidités influencent-elles les traitements ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Les comorbidités peuvent nécessiter des ajustements de traitement pour éviter les complications." } }, { "@type": "Question", "name": "Quel rôle joue la génétique dans les facteurs de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "La génétique peut influencer la réponse aux médicaments et le risque d'effets indésirables." } }, { "@type": "Question", "name": "Comment les habitudes de vie affectent-elles la santé médicamenteuse ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Les habitudes comme le tabagisme ou l'alimentation peuvent modifier l'efficacité des médicaments." } }, { "@type": "Question", "name": "Quels outils évaluent les facteurs de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Des questionnaires et des modèles prédictifs sont utilisés pour évaluer les facteurs de risque." } } ] } ] }

Sources (10000 au total)

A quantitative assessment of the consistency of projections from five mathematical models of the HIV epidemic in South Africa: a model comparison study.

Mathematical models are increasingly used to inform HIV policy and planning. Comparing estimates obtained using different mathematical models can test the robustness of estimates and highlight researc... The five modelling groups produced estimates of the total population, HIV incidence, HIV prevalence, proportion of people living with HIV who are diagnosed, ART coverage, proportion of those on ART wh... For most outputs there was significant inter-model variability between 1990 and 2005, when limited data was available for calibration, good consistency from 2005 to 2025, and increasing variability to... While models produced consistent estimates for several outputs, there are areas of variability that should be investigated. This is important if projections are to be used in subsequent cost-effective...

Comparing bone shape models from deep learning processing of magnetic resonance imaging to computed tomography-based models.

The purpose of this study was to develop a deep learning approach to automatically segment the scapular bone on magnetic resonance imaging (MRI) images and to compare the accuracy of these three-dimen... Fifty-five patients with high-resolution 3D fat-saturated T2 MRI were retrospectively identified. The underlying pathology included rotator cuff tendinopathy and tears, shoulder instability, and impin... The 2D and 3D models achieved a best DSC of 0.86 and 0.82, respectively, with no significant difference observed. Augmentation of imaging data significantly improved 3D but not 2D model performance. I... We have presented a fully automatic, deep learning-based strategy for extracting scapular shape from a high-resolution MRI scan. Further developments of this technology have the potential to allow for...

Testing previously proposed models of the Tonic Immobility Scale in a peritraumatic sample of Israeli civilians: Support for a three-factor model.

Tonic immobility (TI) is a peritraumatic response to extreme threats. It is associated with trauma psychopathology and poor treatment outcomes. Yet, previous psychometric evaluations have yielded inco... A sample of Israeli adults was culled from an online survey following rocket attacks. Confirmatory factor analysis was applied to test the previously proposed models, and Pearson's correlations were u... The best representation of the data was provided by a three-factor model with latent constructs of TI, fear, and detachment. All three peritraumatic responses had significant correlations with peritra... This study supports using a three-factor model with latent constructs, and the scale appears to be psychometrically sound when translated into Hebrew. Future research should seek to replicate these fi...

A classification model for detection of ductal carcinoma in situ by Fourier transform infrared spectroscopy based on deep structured semantic model.

At present, deep learning is widely used in spectral data processing. Deep learning requires a large amount of data for training, while the collection of biological serum spectra is limited by sample ...

Improving Muscle Force Distribution Model Using Reflex Excitation: Towards A Model-Based Exoskeleton Torque Optimization Approach.

In this study, we improve the existing model for force distribution over the muscles by considering reflex excitation as a nonvoluntary mechanism of our neuromuscular system. The improved model can ex... To support our hypothesis and the proposed method, we utilize two experimental datasets for exoskeleton torque optimization; passive and active ankle exoskeletons. First, we use the passive exoskeleto... It is assumed that joint kinematic and reflex gains are fixed with and without exoskeleton.... 74% of biological torque at the ankle joint cannot be experimentally compensated and the existing models can only explain that 17% of the biological torque is uncompensable. Our improved model can exp...